Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Injuries 2Medulloblastoma 2Fatigue 2Choroid Plexus Neoplasms 2Breast Neoplasms 2Astrocytoma 2Spinal Cord Neoplasms 1Sleep Wake Disorders 1Pinealoma 1Pain 1Optic Nerve Glioma 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Memory Disorders 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Familial ependymoma 1Ependymoma 1Depression 1Craniopharyngioma 1Cognitive Dysfunction 1Cognition Disorders 1Central Nervous System Neoplasms 1Cancer Pain 1

Interventions

Sugars 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Memory Disorders × Donepezil × Clear all
NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed
276 enrolled 33 charts
Breast

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡